Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion type Assertion NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_head.
- NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion description "[Further studies of the AQP3, CASP14, ALOX12B, and CLDN1 contributions to chemoresistance may assist in developing novel microRNA-based therapies for human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_provenance.
- NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion evidence source_evidence_literature NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_provenance.
- NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion SIO_000772 24070899 NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_provenance.
- NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion wasDerivedFrom befree-20150227 NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_provenance.
- NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_assertion wasGeneratedBy ECO_0000203 NP814668.RAjj8YxV6qHRdk3eAbl7D-6Pqv3vOFjliBO0lW97cuc8c130_provenance.